A sports management scholar weighs in on the potential consequences of holding Big Ten football games in the fall instead of waiting for a vaccine or better safety procedures.
How much longer must society wait for a vaccine?
ANDRZEJ WOJCICKI/Getty Images
A lab technician holds a vial of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand on May 25, 2020.
(AP Photo/Sakchai Lalit)
Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.
Trucks, planes and storage facilities all need to be able to keep a vaccine cold.
J2R/iStock via Getty Images Plus
The cold supply chain keeps vaccines fresh during distribution, but the current system is nowhere near large enough to distribute the billions of COVID-19 vaccines that the world needs.
Production limits mean that not everyone can get access to a COVID-19 vaccine as soon as it’s developed..
GIPhotoStock/Cultura via Getty Images
Malaria, tuberculosis and HIV/AIDS are regarded as the ‘big three’ infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
A patient receives a shot in a clinical trial for a COVID-19 vaccine.
AP Photo/Ted S. Warren
Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won’t happen unless people believe it’s safe.
The phase 3 trials of the University of Oxford/AstraZeneca vaccine have been paused because one participant became unwell. But we don’t know for sure if the illness was a reaction to the vaccine.
A researcher working on the University of Oxford/AstraZeneca vaccine in Buenos Aires.
EPA-EFE
The Australian government is working with two major pharmaceutical companies to facilitate the local production and supply of two different COVID-19 vaccines – if they’re proven to be effective.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand